Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease

Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzh...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 156; no. 2; pp. 162 - 181
Main Authors Soares Martins, Tânia, Trindade, Dário, Vaz, Margarida, Campelo, Inês, Almeida, Martim, Trigo, Guilherme, da Cruz e Silva, Odete A. B., Henriques, Ana Gabriela
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.01.2021
Subjects
Online AccessGet full text
ISSN0022-3042
1471-4159
1471-4159
DOI10.1111/jnc.15112

Cover

Abstract Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future. Blood‐derived exosomes as potential Alzheimer's disease biomarker resources. Exosomes can be secreted by the central nervous cells, including from neurons (in yellow) and astrocytes (in green) and cross the blood–brain barrier, being easily accessible in peripheral biofluids, like blood. These exosomes can transport Alzheimer's disease (AD) pathogenic content, as Aβ peptide (in red), Tau (the grey curved form) and P‐Tau proteins (the grey curved form with small red dots), but also nucleic acids (in black), supporting their use as suitable tools in biomarker discovery for AD diagnostics or therapeutics.
AbstractList Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future.
Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future.Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future.
Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future. Blood‐derived exosomes as potential Alzheimer's disease biomarker resources. Exosomes can be secreted by the central nervous cells, including from neurons (in yellow) and astrocytes (in green) and cross the blood–brain barrier, being easily accessible in peripheral biofluids, like blood. These exosomes can transport Alzheimer's disease (AD) pathogenic content, as Aβ peptide (in red), Tau (the grey curved form) and P‐Tau proteins (the grey curved form with small red dots), but also nucleic acids (in black), supporting their use as suitable tools in biomarker discovery for AD diagnostics or therapeutics.
Author Campelo, Inês
Trindade, Dário
Vaz, Margarida
Trigo, Guilherme
da Cruz e Silva, Odete A. B.
Soares Martins, Tânia
Almeida, Martim
Henriques, Ana Gabriela
Author_xml – sequence: 1
  givenname: Tânia
  orcidid: 0000-0003-3017-2092
  surname: Soares Martins
  fullname: Soares Martins, Tânia
  organization: University of Aveiro
– sequence: 2
  givenname: Dário
  orcidid: 0000-0002-8536-4609
  surname: Trindade
  fullname: Trindade, Dário
  organization: University of Aveiro
– sequence: 3
  givenname: Margarida
  orcidid: 0000-0001-5425-1495
  surname: Vaz
  fullname: Vaz, Margarida
  organization: University of Aveiro
– sequence: 4
  givenname: Inês
  surname: Campelo
  fullname: Campelo, Inês
  organization: University of Aveiro
– sequence: 5
  givenname: Martim
  surname: Almeida
  fullname: Almeida, Martim
  organization: University of Aveiro
– sequence: 6
  givenname: Guilherme
  surname: Trigo
  fullname: Trigo, Guilherme
  organization: University of Aveiro
– sequence: 7
  givenname: Odete A. B.
  orcidid: 0000-0003-3718-9874
  surname: da Cruz e Silva
  fullname: da Cruz e Silva, Odete A. B.
  organization: University of Aveiro Campus
– sequence: 8
  givenname: Ana Gabriela
  orcidid: 0000-0003-0851-6979
  surname: Henriques
  fullname: Henriques, Ana Gabriela
  email: aghenriques@ua.pt
  organization: University of Aveiro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32618370$$D View this record in MEDLINE/PubMed
BookMark eNp1kc9O3DAQxq2Kqiy0h74AisSlPWTxOLbXOaItbUGIXtqz5Y0n4FViL3Yi_px4DV6PJ8GwuxdU5jKa0e_7NJpvj-z44JGQr0CnkOto6ZspCAD2gUyAz6DkIOodMqGUsbKinO2SvZSWlILkEj6R3YpJUNWMTsjpD2cufUiDawrjbTFcYTQrHF_mVRjQD850RWgLvA0p9JgK54vj7v4KXY_x6eExFdYlNAk_k4-t6RJ-2fR98u_nyd_57_L8z6_T-fF52XCoWamoFXUtamWUbWWlTMOplFSJGWsXswasyEsGglvGJfK2XrRWGBCWKiNtpap98m3tu4rhesQ06N6lBrvOeAxj0owzCpXglGb08A26DGP0-bpMKV5TqaDO1MGGGhc9Wr2KrjfxTm-flIGjNdDEkFLEVjduMIMLfojGdRqofolB5xj0awxZ8f2NYmv6P3bjfuM6vHsf1GcX87XiGfxPlRc
CitedBy_id crossref_primary_10_3390_ph15010076
crossref_primary_10_1002_pmic_202300063
crossref_primary_10_1186_s40779_023_00453_z
crossref_primary_10_1016_j_critrevonc_2022_103628
crossref_primary_10_2147_JIR_S466821
crossref_primary_10_1007_s12035_022_02762_1
crossref_primary_10_3390_cancers14030732
crossref_primary_10_1002_alz_12723
crossref_primary_10_3389_fnins_2021_738442
crossref_primary_10_1021_acs_analchem_3c00215
crossref_primary_10_1111_prd_12561
crossref_primary_10_1111_jnc_16224
crossref_primary_10_3390_chemosensors11110554
crossref_primary_10_3389_fnagi_2022_785741
crossref_primary_10_3390_ijms241713161
crossref_primary_10_1111_jnc_15655
crossref_primary_10_1002_biof_1875
crossref_primary_10_1002_adbi_202400623
crossref_primary_10_3390_futurepharmacol5010011
crossref_primary_10_1016_j_heliyon_2023_e20604
crossref_primary_10_1016_j_lfs_2025_123468
crossref_primary_10_12677_acm_2024_1492563
crossref_primary_10_1080_21655979_2022_2026727
crossref_primary_10_1134_S1819712422020143
crossref_primary_10_1016_j_arr_2024_102483
crossref_primary_10_1111_jnc_70027
crossref_primary_10_1016_j_jsps_2023_101888
crossref_primary_10_1002_alz_14087
crossref_primary_10_1002_jev2_12233
crossref_primary_10_1016_j_lfs_2024_122987
crossref_primary_10_18632_aging_203508
crossref_primary_10_1007_s11064_022_03563_7
crossref_primary_10_2174_1567205019666220202120638
crossref_primary_10_3390_metabo13040479
crossref_primary_10_12677_ACM_2023_132185
crossref_primary_10_1186_s40035_022_00326_w
crossref_primary_10_3390_jcm13226960
crossref_primary_10_1016_j_biocel_2022_106262
crossref_primary_10_3748_wjg_v30_i6_527
crossref_primary_10_1016_j_bios_2021_113864
crossref_primary_10_1007_s00216_022_04174_5
crossref_primary_10_1002_mco2_287
crossref_primary_10_1097_YCO_0000000000000842
crossref_primary_10_1016_j_bios_2025_117362
crossref_primary_10_1007_s10787_024_01466_3
crossref_primary_10_1016_j_bios_2023_115269
crossref_primary_10_1016_j_colsurfb_2024_113938
crossref_primary_10_1186_s13195_021_00791_x
crossref_primary_10_5483_BMBRep_2022_55_1_162
crossref_primary_10_1021_acsami_3c16839
crossref_primary_10_1021_acsami_3c12766
crossref_primary_10_2174_0113862073261891231115072310
crossref_primary_10_1002_rcm_9427
crossref_primary_10_3390_antiox13030316
crossref_primary_10_1016_j_neubiorev_2022_104974
crossref_primary_10_3390_brainsci14111049
crossref_primary_10_3390_ijms242216259
crossref_primary_10_3390_ijms26010189
crossref_primary_10_1097_ONO_0000000000000027
crossref_primary_10_4103_NRR_NRR_D_24_00462
crossref_primary_10_1186_s43556_021_00040_5
crossref_primary_10_1016_j_bbrc_2025_151526
crossref_primary_10_3390_ijms23094610
crossref_primary_10_3390_ijms22179543
crossref_primary_10_1002_smll_202409806
crossref_primary_10_3389_fneur_2023_1059492
crossref_primary_10_1038_s41374_021_00644_z
crossref_primary_10_3389_fnagi_2022_977411
crossref_primary_10_1002_adsr_202400002
crossref_primary_10_1111_jnc_15697
crossref_primary_10_1016_j_jsps_2023_01_009
crossref_primary_10_1016_j_critrevonc_2022_103799
crossref_primary_10_1038_s41538_024_00250_5
crossref_primary_10_1002_btm2_10203
crossref_primary_10_3390_ijms221910794
crossref_primary_10_1093_labmed_lmae039
crossref_primary_10_1080_08820139_2024_2440772
crossref_primary_10_3390_biomedicines9030252
crossref_primary_10_1159_000528886
crossref_primary_10_3390_ijms23158082
crossref_primary_10_1002_pmic_202200515
crossref_primary_10_1192_j_eurpsy_2022_2319
crossref_primary_10_3390_ijms22083933
crossref_primary_10_1016_j_cclet_2022_107926
crossref_primary_10_15616_BSL_2021_27_4_208
crossref_primary_10_3389_fgene_2023_1249678
crossref_primary_10_1016_j_jconrel_2022_06_011
crossref_primary_10_1093_stcltm_szad004
crossref_primary_10_1051_medsci_2024037
crossref_primary_10_3390_jcm12041459
crossref_primary_10_1016_j_biopha_2023_115407
crossref_primary_10_1515_mr_2023_0071
crossref_primary_10_3389_fncel_2020_590034
crossref_primary_10_1089_cell_2023_0001
crossref_primary_10_1097_MD_0000000000027319
crossref_primary_10_3390_ijms23147986
crossref_primary_10_3389_fnagi_2025_1496252
crossref_primary_10_3389_fncel_2021_743353
crossref_primary_10_1186_s13024_021_00474_z
crossref_primary_10_3390_ijms22031365
crossref_primary_10_1155_2022_6742792
crossref_primary_10_1007_s12640_022_00621_4
crossref_primary_10_1016_j_ccr_2021_214325
crossref_primary_10_1038_s41368_022_00187_z
crossref_primary_10_1007_s12013_024_01564_7
crossref_primary_10_3390_ijms25147794
crossref_primary_10_3390_ph16040540
crossref_primary_10_3389_fnagi_2022_860364
crossref_primary_10_2174_1574888X18666230726161035
crossref_primary_10_3390_pharmaceutics15041216
crossref_primary_10_1016_j_sciaf_2024_e02274
Cites_doi 10.1371/journal.pone.0208580
10.3233/JAD-2009-1177
10.1074/jbc.M111.277061
10.1074/jbc.M114.605253
10.1002/prca.200700522
10.1016/S0006-291X(02)02999-6
10.3892/mmr.2014.2484
10.1074/jbc.M117.818138
10.1016/0092-8674(91)90459-C
10.1155/2018/8545347
10.3389/fnagi.2017.00012
10.1016/j.jconrel.2015.03.033
10.1073/pnas.0603838103
10.3233/JAD-132135
10.4132/jptm.2017.05.21
10.1186/s40478-017-0445-5
10.3233/JAD-142664
10.3389/fphar.2017.00910
10.3389/fncel.2019.00264
10.1186/1756-6606-6-47
10.7150/thno.21945
10.1242/jcs.115.12.2505
10.1186/s13024-016-0143-y
10.1007/s11011-019-00438-9
10.1111/j.1471-4159.2007.04587.x
10.1007/s00401-018-1868-1
10.1016/j.pharmthera.2018.08.002
10.4103/1673-5374.255978
10.1371/journal.pone.0041561
10.1523/JNEUROSCI.1429-16.2016
10.1016/j.bbamcr.2009.09.011
10.1016/j.dadm.2016.04.001
10.1038/srep07989
10.1016/j.devcel.2011.08.019
10.1016/j.mcn.2010.11.004
10.1096/fj.201600756R
10.1073/pnas.96.7.3922
10.1007/s11010-009-0084-7
10.1016/j.bbrc.2006.10.181
10.1083/jcb.201504136
10.1096/fj.14-262048
10.1080/21541248.2016.1264352
10.3402/jev.v3.24722
10.1007/s11064-019-02742-3
10.1016/j.febslet.2014.11.027
10.1083/jcb.200911018
10.1007/s12640-017-9713-1
10.1186/s13024-019-0333-5
10.1074/jbc.M110.149468
10.1073/pnas.0308512100
10.1007/s12031-007-0001-z
10.1074/jbc.273.43.27765
10.1523/JNEUROSCI.0387-15.2015
10.1111/bpa.12699
10.1096/fj.201700359
10.1038/s41467-017-02533-w
10.3389/fncel.2013.00182
10.1038/ncomms13588
10.1212/WNL.0000000000001702
10.1074/jbc.M609475200
10.1016/S0140-6736(06)69113-7
10.1016/j.neuroscience.2018.04.003
10.1074/jbc.M112.404467
10.3171/2014.11.JNS14770
10.1016/j.dadm.2018.11.002
10.1111/j.1600-0854.2009.00920.x
10.1146/annurev-cellbio-101512-122326
10.1186/s13024-017-0165-0
10.1038/npjamd.2016.19
10.1016/j.jalz.2014.06.008
10.7150/thno.18133
10.1007/s12035-018-1032-x
10.1074/jbc.M112.445304
10.2217/bmm-2018-0034
10.1039/C9NR01255A
10.1007/s10571-019-00751-y
10.1002/ana.25172
10.1042/bj3430371
10.3233/JAD-191034
10.1016/j.febslet.2008.05.002
10.3233/JAD-170278
10.3233/JAD-132144
10.1016/j.jalz.2016.08.012
10.1074/jbc.M110.134775
10.1038/nn.4132
10.2174/1567205016666190321155422
10.3390/ijms20071728
10.3389/fphar.2019.01452
10.1093/brain/awq258
10.1016/j.neurobiolaging.2014.02.012
10.1038/srep01197
10.1007/s11095-014-1593-y
10.1016/j.biochi.2018.05.015
10.1016/j.jalz.2019.06.4952
10.1038/nature14864
10.1007/s00702-008-0177-6
10.1096/fj.201600816R
10.2174/1567205014666170317113606
10.1007/s12035-019-1501-x
10.1096/fj.201700731R
10.1038/srep30319
10.1093/brain/awy289
10.1371/journal.pone.0198820
10.1038/cdd.2013.180
10.1016/j.jneumeth.2018.10.025
10.1186/s40035-019-0169-5
10.3233/JAD-2010-1371
10.1074/jbc.M111.324616
10.1186/s13024-017-0203-y
10.1101/cshperspect.a006270
10.1016/j.neuroscience.2018.03.016
10.3389/fnins.2018.00383
10.1016/j.nbd.2018.02.014
10.3389/fnins.2019.01208
10.3233/JAD-170176
10.1016/j.jalz.2019.05.002
10.1371/journal.pbio.1001604
10.1186/gm452
10.1096/fj.201801001
10.2174/187152710793237458
10.1016/j.brainres.2018.03.034
10.1111/j.1471-4159.2008.05770.x
10.3389/fncel.2019.00051
10.1074/jbc.M114.577213
10.1038/nbt.1807
10.1096/fj.201700600R
10.1007/7651_2014_98
10.1038/s41598-019-45676-0
10.1016/j.cub.2012.01.028
10.1038/s41582-018-0079-7
10.1155/2016/2584940
10.1096/fj.201801319R
10.1096/fj.07-9357com
10.1007/s12079-019-00524-8
10.3233/JAD-180578
10.1074/jbc.M115.709485
10.3233/JAD-2008-14103
10.2217/fon-2018-0812
10.18632/oncotarget.6158
10.3390/ijms19030663
10.1093/nar/gku594
10.1074/jbc.M112.340513
10.1038/ncb2000
10.1111/j.1600-0854.2004.00257.x
10.3233/JAD-2010-1206
10.1242/jcs.215210
10.3233/JAD-180776
10.1002/hbm.23494
10.1016/S0002-9440(10)64463-X
10.1007/s11064-018-2641-5
10.1038/mp.2014.127
10.1001/jamaneurol.2019.2462
10.1186/s40478-018-0514-4
10.1242/jcs.128868
10.1371/journal.pone.0139233
10.1038/s41467-019-09030-2
10.1016/j.neurobiolaging.2009.08.013
10.1126/science.1153124
10.1002/acn3.211
ContentType Journal Article
Copyright 2020 International Society for Neurochemistry
2020 International Society for Neurochemistry.
Copyright © 2021 International Society for Neurochemistry
Copyright_xml – notice: 2020 International Society for Neurochemistry
– notice: 2020 International Society for Neurochemistry.
– notice: Copyright © 2021 International Society for Neurochemistry
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
7X8
DOI 10.1111/jnc.15112
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Chemoreception Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1471-4159
EndPage 181
ExternalDocumentID 32618370
10_1111_jnc_15112
JNC15112
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: FCT stimulus of scientific employment individual support
  funderid: CEECIND/01803/2017
– fundername: FCT through the individual PhD grant
  funderid: SFRH/BD/145979/2019
– fundername: Integrated Programme of SR&TD “pAGE” ‐ CENTRO 2020 ‐ CENTRO‐01‐0145‐FEDER‐000003, co‐funded by Centro 2020 program, Portugal 2020, European Union, through the European Regional Development Fund CENTRO 2020
– fundername: Alzheimer's Association Grant 2019‐AARG‐644347
– fundername: PTDC/DTPPIC/5587/2014 and POCI‐01‐0145‐FEDER‐016904 and also by Instituto de Biomedicina (iBiMED) ‐ UIDB/04501/2020, the Fundação para a Ciência e Tecnologia (FCT) of the Ministério da Educação e Ciência, COMPETE program, the QREN and the European Union (Fundo Europeu de Desenvolvimento Regional)
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29L
2WC
31~
33P
36B
3SF
4.4
41~
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYJJ
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOD
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GAKWD
GODZA
GX1
H.X
HF~
HGLYW
HH5
HVGLF
HZI
HZ~
IH2
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TWZ
UB1
V8K
VH1
W8V
W99
WBKPD
WIH
WIJ
WIK
WIN
WNSPC
WOHZO
WOW
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
X7M
XG1
XJT
YFH
YNH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QR
7TK
7U7
7U9
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
FR3
H94
P64
7X8
ID FETCH-LOGICAL-c4192-80d599598a8df638ac406608572fb7c1d56382154d246e4f9bfd5a15d08a6d383
IEDL.DBID DR2
ISSN 0022-3042
1471-4159
IngestDate Fri Jul 11 04:14:54 EDT 2025
Fri Jul 25 19:32:13 EDT 2025
Thu Apr 03 07:07:47 EDT 2025
Tue Jul 01 04:39:38 EDT 2025
Thu Apr 24 22:59:00 EDT 2025
Wed Jan 22 16:32:06 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords diagnosis
therapeutics
biomarker
Alzheimer's Disease
exosome
Language English
License 2020 International Society for Neurochemistry.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4192-80d599598a8df638ac406608572fb7c1d56382154d246e4f9bfd5a15d08a6d383
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-0851-6979
0000-0003-3017-2092
0000-0003-3718-9874
0000-0001-5425-1495
0000-0002-8536-4609
PMID 32618370
PQID 2484906819
PQPubID 31528
PageCount 20
ParticipantIDs proquest_miscellaneous_2420135400
proquest_journals_2484906819
pubmed_primary_32618370
crossref_citationtrail_10_1111_jnc_15112
crossref_primary_10_1111_jnc_15112
wiley_primary_10_1111_jnc_15112_JNC15112
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2021
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: January 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Journal of neurochemistry
PublicationTitleAlternate J Neurochem
PublicationYear 2021
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2010; 12
2007; 102
2013; 3
2010; 19
2019; 11
2019; 10
2019; 13
2013; 126
2010; 189
2019; 15
2019; 14
2019; 16
2016; 30
2016; 2016
2013; 7
2018; 43
2013; 5
2013; 6
2008; 582
2016; 36
2014; 21
2009; 116
1998; 273
2018; 6
2018; 9
2018; 8
2010; 20
2009; 10
2019; 20
2019; 29
2008; 22
2007; 1
2018; 33
2018; 32
2012; 22
2018; 31
2009; 1793
2009; 18
2010; 9
2014; 10
2019; 8
2019; 9
2017; 60
2007; 282
2019; 33
2015; 122
2019; 34
2015; 1212
2010; 285
2015; 526
1999; 343
2014; 40
2015b; 85
2014; 42
2018; 19
2016; 6
2016; 7
2018; 192
2019; 40
2016; 2
2016; 3
2017; 58
1991; 65
2019; 44
2018; 114
2014; 35
2005; 6
2018; 12
2014; 30
2009; 108
2016; 291
2018; 14
2006; 103
2018; 13
2015; 35
2017; 5
2017; 7
2017; 8
2012; 287
2015; 589
2019; 56
2015; 32
2013; 288
2002; 115
2019; 405
2018; 83
2007; 32
2017; 9
2018; 131
2015; 45
2017; 31
2015; 290
2014; 3
2013; 11
2017; 38
2015; 211
2017; 32
2018; 379
2019; 69
2018; 136
2008; 319
2011; 21
2015a; 2
1999; 96
2006; 368
2009; 328
2011; 29
2014; 289
2004; 101
2015; 6
2015; 5
2015; 18
2017; 2017
2019; 76
2018; 1691
2015; 11
2015; 10
2008; 14
2017; 292
2011; 32
2015; 207
2018; 67
2019; 142
2018; 155
2012; 2
2018; 2018
2002; 161
2015; 29
2017; 14
2020; 74
2015; 20
2007; 352
2017; 13
2017; 12
2010; 133
2018; 52
2011; 46
2018; 319
2003; 301
2018; 55
2012; 7
e_1_2_9_75_1
e_1_2_9_98_1
e_1_2_9_52_1
e_1_2_9_79_1
e_1_2_9_94_1
e_1_2_9_10_1
e_1_2_9_56_1
e_1_2_9_33_1
e_1_2_9_90_1
e_1_2_9_71_1
e_1_2_9_103_1
e_1_2_9_126_1
e_1_2_9_149_1
e_1_2_9_107_1
e_1_2_9_122_1
e_1_2_9_145_1
e_1_2_9_14_1
e_1_2_9_141_1
e_1_2_9_37_1
e_1_2_9_18_1
e_1_2_9_160_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_87_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_83_1
e_1_2_9_6_1
e_1_2_9_119_1
e_1_2_9_60_1
e_1_2_9_2_1
e_1_2_9_138_1
e_1_2_9_111_1
e_1_2_9_134_1
e_1_2_9_115_1
e_1_2_9_157_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_130_1
e_1_2_9_153_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_99_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_95_1
e_1_2_9_76_1
e_1_2_9_91_1
e_1_2_9_102_1
e_1_2_9_148_1
e_1_2_9_129_1
e_1_2_9_144_1
e_1_2_9_106_1
e_1_2_9_125_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_140_1
e_1_2_9_121_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_88_1
e_1_2_9_61_1
e_1_2_9_46_1
e_1_2_9_84_1
e_1_2_9_23_1
e_1_2_9_65_1
e_1_2_9_80_1
e_1_2_9_5_1
e_1_2_9_114_1
e_1_2_9_137_1
e_1_2_9_118_1
e_1_2_9_133_1
e_1_2_9_156_1
e_1_2_9_9_1
e_1_2_9_152_1
e_1_2_9_27_1
e_1_2_9_69_1
e_1_2_9_110_1
e_1_2_9_31_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_35_1
e_1_2_9_77_1
e_1_2_9_96_1
e_1_2_9_12_1
e_1_2_9_54_1
e_1_2_9_92_1
e_1_2_9_109_1
e_1_2_9_101_1
e_1_2_9_128_1
Yang T. T. (e_1_2_9_154_1) 2018; 31
e_1_2_9_105_1
e_1_2_9_124_1
e_1_2_9_147_1
e_1_2_9_39_1
e_1_2_9_162_1
e_1_2_9_120_1
e_1_2_9_16_1
e_1_2_9_58_1
e_1_2_9_143_1
e_1_2_9_20_1
e_1_2_9_62_1
e_1_2_9_89_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_85_1
e_1_2_9_8_1
e_1_2_9_81_1
e_1_2_9_4_1
e_1_2_9_113_1
e_1_2_9_159_1
e_1_2_9_117_1
e_1_2_9_155_1
e_1_2_9_136_1
e_1_2_9_151_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_132_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_78_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_97_1
e_1_2_9_93_1
e_1_2_9_108_1
e_1_2_9_70_1
e_1_2_9_127_1
e_1_2_9_100_1
e_1_2_9_123_1
e_1_2_9_104_1
e_1_2_9_146_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
Wang L.‐L. (e_1_2_9_142_1) 2017; 2017
e_1_2_9_161_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_21_1
e_1_2_9_67_1
e_1_2_9_44_1
e_1_2_9_86_1
e_1_2_9_7_1
e_1_2_9_82_1
e_1_2_9_3_1
e_1_2_9_112_1
e_1_2_9_139_1
e_1_2_9_116_1
e_1_2_9_135_1
e_1_2_9_158_1
e_1_2_9_25_1
e_1_2_9_131_1
e_1_2_9_48_1
e_1_2_9_29_1
e_1_2_9_150_1
References_xml – volume: 9
  start-page: 720
  year: 2010
  end-page: 726
  article-title: Wnt signalling is a relevant pathway contributing to amyloid beta‐peptide‐mediated neuropathology in Alzheimers disease
  publication-title: CNS & Neurological Disorders – Drug Targets
– volume: 368
  start-page: 387
  year: 2006
  end-page: 403
  article-title: Alzheimer’s disease
  publication-title: Lancet
– volume: 2016
  start-page: 2584940
  year: 2016
  article-title: Differential DNA methylation of microRNA genes in temporal cortex from Alzheimer’s disease individuals
  publication-title: Neural Plasticity
– volume: 32
  start-page: 2003
  year: 2015
  end-page: 2014
  article-title: Exosome delivered anticancer drugs across the blood‐brain barrier for brain cancer therapy in Danio rerio
  publication-title: Pharmaceutical Research
– volume: 35
  start-page: 10851
  year: 2015
  end-page: 10865
  article-title: C‐terminally truncated forms of tau, but not full‐length tau or its C‐terminal fragments, are released from neurons independently of cell death
  publication-title: Journal of Neuroscience
– volume: 1212
  start-page: 171
  year: 2015
  end-page: 181
  article-title: Potential application of extracellular vesicles of human adipose tissue‐derived mesenchymal stem cells in Alzheimer’s disease therapeutics
  publication-title: Methods in Molecular Biology
– volume: 287
  start-page: 10977
  year: 2012
  end-page: 10989
  article-title: Sphingolipid‐modulated exosome secretion promotes clearance of amyloid‐β by microglia
  publication-title: Journal of Biological Chemistry
– volume: 96
  start-page: 3922
  year: 1999
  end-page: 3927
  article-title: Constitutive and regulated alpha‐secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
– volume: 10
  start-page: 2395
  year: 2014
  end-page: 2400
  article-title: MicroRNA‐193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA‐193b is a biomarker of Alzheimer’s disease
  publication-title: Molecular Medicine Reports
– volume: 589
  start-page: 84
  year: 2015
  end-page: 88
  article-title: A potential function for neuronal exosomes: Sequestering intracerebral amyloid‐β peptide
  publication-title: FEBS Letters
– volume: 13
  start-page: 264
  year: 2019
  article-title: Glutaminase C regulates microglial activation and pro‐inflammatory exosome release: Relevance to the pathogenesis of Alzheimer’s disease
  publication-title: Frontiers in Cellular Neuroscience
– volume: 133
  start-page: 3699
  year: 2010
  end-page: 3723
  article-title: Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer’s disease
  publication-title: Brain
– volume: 15
  start-page: 1071
  year: 2019
  end-page: 1080
  article-title: Concordance between the assessment of Aβ42, T‐tau, and P‐T181‐tau in peripheral blood neuronal‐derived exosomes and cerebrospinal fluid
  publication-title: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
– volume: 20
  start-page: 275
  year: 2010
  end-page: 292
  article-title: Grb2‐mediated alteration in the trafficking of AbetaPP: Insights from Grb2‐AICD interaction
  publication-title: Journal of Alzheimer's Disease
– volume: 6
  start-page: 131
  year: 2005
  end-page: 143
  article-title: Rab11 promotes docking and fusion of multivesicular bodies in a calcium‐dependent manner
  publication-title: Traffic
– volume: 10
  start-page: 925
  year: 2009
  end-page: 937
  article-title: Multivesicular endosome Biogenesis in the absence of ESCRTs
  publication-title: Traffic
– volume: 379
  start-page: 167
  year: 2018
  end-page: 176
  article-title: Serum exosomal miR‐223 serves as a potential diagnostic and prognostic biomarker for dementia
  publication-title: Neuroscience
– volume: 36
  start-page: 8653
  year: 2016
  end-page: 8667
  article-title: Neutral sphingomyelinase‐2 deficiency ameliorates Alzheimer’s disease pathology and improves cognition in the 5XFAD mouse
  publication-title: Journal of Neuroscience
– volume: 5
  start-page: 46
  year: 2017
  article-title: Brain‐derived exosomes from dementia with Lewy bodies propagate α‐synuclein pathology
  publication-title: Acta Neuropathologica Communications
– volume: 8
  start-page: 910
  year: 2017
  article-title: ATP modifies the proteome of extracellular vesicles released by microglia and influences their action on astrocytes
  publication-title: Frontiers in Pharmacology
– volume: 114
  start-page: 120
  year: 2018
  end-page: 128
  article-title: Neuronal pentraxin 1: A synaptic‐derived plasma biomarker in Alzheimer’s disease
  publication-title: Neurobiology of Diseases
– volume: 3
  start-page: 63
  year: 2016
  end-page: 72
  article-title: Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile
  publication-title: Alzheimer’s Dement
– volume: 161
  start-page: 1869
  year: 2002
  end-page: 1879
  article-title: Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology
  publication-title: American Journal of Pathology
– volume: 35
  start-page: 1792
  year: 2014
  end-page: 1800
  article-title: Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease
  publication-title: Neurobiology of Aging
– volume: 38
  start-page: 1933
  year: 2017
  end-page: 1940
  article-title: Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer’s disease
  publication-title: Human Brain Mapping
– volume: 2
  start-page: 16019
  year: 2016
  article-title: Extracellular vesicle‐associated Aβ mediates trans‐neuronal bioenergetic and Ca2+‐handling deficits in Alzheimer’s disease models
  publication-title: NPJ Aging and Mechanisms of Disease.
– volume: 20
  start-page: 1188
  year: 2015
  end-page: 1196
  article-title: Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment
  publication-title: Molecular Psychiatry
– volume: 13
  year: 2018
  article-title: Exosome isolation from distinct biofluids using precipitation and column‐based approaches
  publication-title: PLoS One
– volume: 22
  start-page: R116
  year: 2012
  end-page: R120
  article-title: The ESCRT machinery
  publication-title: Current Biology
– volume: 12
  start-page: 5
  year: 2017
  article-title: The release and trans‐synaptic transmission of Tau via exosomes
  publication-title: Molecular Neurodegeneration
– volume: 11
  start-page: 61
  year: 2019
  end-page: 66
  article-title: Complement protein levels in plasma astrocyte‐derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer’s disease dementia
  publication-title: Alzheimer’s Dement. (amsterdam, Netherlands)
– volume: 32
  start-page: 1435
  year: 2011
  end-page: 1442
  article-title: Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer’s disease
  publication-title: Neurobiology of Aging
– volume: 52
  start-page: 1
  year: 2018
  end-page: 8
  article-title: Extracellular vesicles and the promise of continuous liquid biopsies
  publication-title: Journal of Pathology and Translational Medicine
– volume: 13
  start-page: 1208
  year: 2019
  article-title: miR‐212 and miR‐132 are downregulated in neurally derived plasma exosomes of Alzheimer’s patients
  publication-title: Frontiers in Neuroscience
– volume: 14
  start-page: 639
  year: 2018
  end-page: 652
  article-title: Blood‐based biomarkers for Alzheimer disease: Mapping the road to the clinic
  publication-title: Nature Reviews. Neurology
– volume: 15
  start-page: 801
  year: 2019
  end-page: 803
  article-title: Why have microRNA biomarkers not been translated from bench to clinic?
  publication-title: Future Oncology
– volume: 5
  start-page: 48
  year: 2013
  article-title: Genes and pathways underlying regional and cell type changes in Alzheimer’s disease
  publication-title: Genome Medicine
– volume: 12
  start-page: 19
  year: 2010
  end-page: 30
  article-title: Rab27a and Rab27b control different steps of the exosome secretion pathway
  publication-title: Nature Cell Biology
– volume: 189
  start-page: 223
  year: 2010
  end-page: 232
  article-title: Regulation of exosome secretion by Rab35 and its GTPase‐activating proteins TBC1D10A–C
  publication-title: Journal of Cell Biology
– volume: 10
  start-page: 1452
  year: 2019
  article-title: Exosomes from astrocyte processes: Signaling to neurons
  publication-title: Front. Pharmacol.
– volume: 282
  start-page: 18197
  year: 2007
  end-page: 18205
  article-title: Alkalizing drugs induce accumulation of amyloid precursor protein by‐products in luminal vesicles of multivesicular bodies
  publication-title: Journal of Biological Chemistry
– volume: 102
  start-page: 619
  year: 2007
  end-page: 626
  article-title: Alzheimer’s presenilin 1 modulates sorting of APP and its carboxyl‐terminal fragments in cerebral neurons in vivo
  publication-title: Journal of Neurochemistry
– volume: 1
  start-page: 1446
  year: 2007
  end-page: 1461
  article-title: Oligodendrocytes secrete exosomes containing major myelin and stress‐protective proteins: Trophic support for axons?
  publication-title: Proteomics ‐ Clin. Appl.
– volume: 40
  start-page: 1017
  year: 2014
  end-page: 1027
  article-title: Genome‐wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer’s disease
  publication-title: Journal of Alzheimer's Disease
– volume: 3
  start-page: 1
  year: 2014
  article-title: Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons
  publication-title: Journal of Extracellular Vesicles
– volume: 12
  start-page: 25
  year: 2017
  article-title: Tetraspanin 6: A pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments
  publication-title: Molecular Neurodegeneration
– volume: 10
  year: 2015
  article-title: Plasma exosomal miRNAs in Persons with and without Alzheimer Disease: Altered expression and prospects for biomarkers
  publication-title: PLoS One
– volume: 13
  year: 2018
  article-title: MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study
  publication-title: PLoS One
– volume: 207
  start-page: 18
  year: 2015
  end-page: 30
  article-title: Exosomes as drug delivery vehicles for Parkinson’s disease therapy
  publication-title: J. Control. Release
– volume: 9
  start-page: 291
  year: 2018
  article-title: Neuronal lysosomal dysfunction releases exosomes harboring APP C‐terminal fragments and unique lipid signatures
  publication-title: Nature Communications
– volume: 3
  start-page: 1197
  year: 2013
  article-title: Human adipose tissue‐derived mesenchymal stem cells secrete functional neprilysin‐bound exosomes
  publication-title: Scientific Reports
– volume: 15
  start-page: 1468
  year: 2019
  end-page: 1477
  article-title: Differential expression of microRNAs in Alzheimer’s disease brain, blood, and cerebrospinal fluid
  publication-title: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
– volume: 301
  start-page: 231
  year: 2003
  end-page: 235
  article-title: Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha‐secretase
  publication-title: Biochemical and Biophysical Research Communications
– volume: 22
  start-page: 1469
  year: 2008
  end-page: 1478
  article-title: Inhibition of gamma‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes
  publication-title: The FASEB Journal
– volume: 30
  start-page: 4141
  year: 2016
  end-page: 4148
  article-title: Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease
  publication-title: The FASEB Journal
– volume: 19
  start-page: 663
  year: 2018
  article-title: Detection of aggregation‐competent tau in neuron‐derived extracellular vesicles
  publication-title: International Journal of Molecular Sciences
– volume: 7
  year: 2012
  article-title: Comparing the MicroRNA spectrum between serum and plasma
  publication-title: PLoS One
– volume: 11
  start-page: 600
  year: 2015
  end-page: 607
  article-title: Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study
  publication-title: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
– volume: 7
  start-page: 13588
  year: 2016
  article-title: ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins
  publication-title: Nature Communications
– volume: 9
  start-page: 95
  year: 2018
  end-page: 106
  article-title: New insights into the function of Rab GTPases in the context of exosomal secretion
  publication-title: Small GTPases
– volume: 6
  start-page: 30319
  year: 2016
  article-title: Altered protein phosphorylation as a resource for potential AD biomarkers
  publication-title: Scientific Reports
– volume: 291
  start-page: 12445
  year: 2016
  end-page: 12466
  article-title: Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold‐dependent manner
  publication-title: Journal of Biological Chemistry
– volume: 155
  start-page: 67
  year: 2018
  end-page: 82
  article-title: Secretome from SH‐SY5Y APPSwe cells trigger time‐dependent CHME3 microglia activation phenotypes, ultimately leading to miR‐21 exosome shuttling
  publication-title: Biochimie
– volume: 352
  start-page: 111
  year: 2007
  end-page: 117
  article-title: ADAM19 is tightly associated with constitutive Alzheimer’s disease APP α‐secretase in A172 cells
  publication-title: Biochemical and Biophysical Research Communications
– volume: 290
  start-page: 3455
  year: 2015
  end-page: 3467
  article-title: The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes
  publication-title: Journal of Biological Chemistry
– volume: 34
  start-page: 1355
  year: 2019
  end-page: 1363
  article-title: Intrahippocampal miR‐342‐3p inhibition reduces β‐amyloid plaques and ameliorates learning and memory in Alzheimer’s disease
  publication-title: Metabolic Brain Disease
– volume: 31
  start-page: 2729
  year: 2017
  end-page: 2743
  article-title: Amyloid precursor protein and endosomal‐lysosomal dysfunction in Alzheimer’s disease: Inseparable partners in a multifactorial disease
  publication-title: The FASEB Journal
– volume: 31
  start-page: 87
  year: 2018
  end-page: 96
  article-title: The serum exosome derived microRNA‐135a, ‐193b, and ‐384 were potential Alzheimer’s disease biomarkers
  publication-title: Biomedical and Environmental Sciences
– volume: 13
  start-page: 51
  year: 2019
  article-title: Extracellular vesicles secreted in response to cytokine exposure increase mitochondrial oxygen consumption in recipient cells
  publication-title: Frontiers in Cellular Neuroscience
– volume: 328
  start-page: 145
  year: 2009
  end-page: 154
  article-title: S655 phosphorylation enhances APP secretory traffic
  publication-title: Molecular and Cellular Biochemistry
– volume: 18
  start-page: 413
  year: 2009
  end-page: 417
  article-title: Cerebrospinal fluid biomarkers for Alzheimer’s disease
  publication-title: Journal of Alzheimer's Disease
– volume: 131
  start-page: jcs215210
  year: 2018
  article-title: The interplay between exosomes and autophagy ‐ partners in crime
  publication-title: Journal of Cell Science
– volume: 122
  start-page: 856
  year: 2015
  end-page: 867
  article-title: Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury
  publication-title: Journal of Neurosurgery
– volume: 14
  start-page: 870
  year: 2017
  end-page: 882
  article-title: Impact of cytokines and chemokines on Alzheimer’s disease neuropathological hallmarks
  publication-title: Current Alzheimer Research
– volume: 405
  start-page: 148
  year: 2019
  end-page: 157
  article-title: Cell‐to‐cell communication by extracellular vesicles: focus on microglia
  publication-title: Neuroscience
– volume: 319
  start-page: 1244
  year: 2008
  end-page: 1247
  article-title: Ceramide triggers budding of exosome vesicles into multivesicular endosomes
  publication-title: Science (80‐. )
– volume: 32
  start-page: 1
  year: 2007
  end-page: 8
  article-title: Tyr687 dependent APP endocytosis and Abeta production
  publication-title: Journal of Molecular Neuroscience
– volume: 55
  start-page: 8826
  year: 2018
  end-page: 8841
  article-title: MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young‐onset Alzheimer’s disease
  publication-title: Molecular Neurobiology
– volume: 142
  start-page: 163
  year: 2019
  end-page: 175
  article-title: Apolipoprotein E4 genotype compromises brain exosome production
  publication-title: Brain
– volume: 287
  start-page: 21384
  year: 2012
  end-page: 21395
  article-title: Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR‐4): Potential mechanism of apoptosis induction in Alzheimer disease (AD)
  publication-title: Journal of Biological Chemistry
– volume: 69
  start-page: 489
  year: 2019
  end-page: 498
  article-title: Extracellular vesicle biomarkers track cognitive changes following intranasal insulin in Alzheimer’s disease
  publication-title: Journal of Alzheimer's Disease
– volume: 58
  start-page: 953
  year: 2017
  end-page: 978
  article-title: Protein phosphorylation is a key mechanism in Alzheimer’s Disease
  publication-title: Journal of Alzheimer's Disease
– volume: 101
  start-page: 2173
  year: 2004
  end-page: 2178
  article-title: Incipient Alzheimer’s disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses
  publication-title: Proceedings of the National Academy of Sciences
– volume: 29
  start-page: 593
  year: 2019
  end-page: 605
  article-title: Brain‐derived and circulating vesicle profiles indicate neurovascular unit dysfunction in early Alzheimer’s disease
  publication-title: Brain Pathology
– volume: 42
  start-page: 9195
  year: 2014
  end-page: 9208
  article-title: Activity‐associated miRNA are packaged in Map1b‐enriched exosomes released from depolarized neurons
  publication-title: Nucleic Acids Research
– volume: 115
  start-page: 2505
  year: 2002
  end-page: 2515
  article-title: The exosome pathway in K562 cells is regulated by Rab11
  publication-title: Journal of Cell Science
– volume: 14
  start-page: 32
  year: 2019
  article-title: The neuropathological diagnosis of Alzheimer’s disease
  publication-title: Molecular Neurodegeneration
– volume: 12
  start-page: 1025
  year: 2018
  end-page: 1033
  article-title: Exosomes as possible spread factor and potential biomarkers in Alzheimer’s disease: Current concepts
  publication-title: Biomark. Med.
– volume: 292
  start-page: 19873
  year: 2017
  end-page: 19889
  article-title: Disruption of amyloid precursor protein ubiquitination selectively increases amyloid β (Aβ) 40 levels via presenilin 2‐mediated cleavage
  publication-title: Journal of Biological Chemistry
– volume: 116
  start-page: 203
  year: 2009
  end-page: 212
  article-title: Combined CSF tau, p‐tau181 and amyloid‐beta 38/40/42 for diagnosing Alzheimer’s disease
  publication-title: Journal of Neural Transmission
– volume: 32
  start-page: 888
  year: 2018
  end-page: 893
  article-title: Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer’s disease
  publication-title: The FASEB Journal
– volume: 46
  start-page: 409
  year: 2011
  end-page: 418
  article-title: Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity
  publication-title: Molecular and Cellular Neurosciences
– volume: 526
  start-page: 443
  year: 2015
  end-page: 447
  article-title: η‐Secretase processing of APP inhibits neuronal activity in the hippocampus
  publication-title: Nature
– volume: 6
  start-page: 37043
  year: 2015
  end-page: 37053
  article-title: Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
  publication-title: Oncotarget
– volume: 18
  start-page: 1584
  year: 2015
  end-page: 1593
  article-title: Depletion of microglia and inhibition of exosome synthesis halt tau propagation
  publication-title: Nature Neuroscience
– volume: 13
  start-page: 541
  year: 2017
  end-page: 549
  article-title: Neuronal exosomes reveal Alzheimer’s disease biomarkers in Down syndrome
  publication-title: Alzheimer’s Dement
– volume: 32
  start-page: 82
  year: 2017
  end-page: 93
  article-title: Exosomes secreted from HEK293‐APP Swe/Ind cells impair the hippocampal neurogenesis
  publication-title: Neurotoxicity Research
– volume: 29
  start-page: 589
  year: 2015
  end-page: 596
  article-title: Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer’s disease
  publication-title: The FASEB Journal
– volume: 40
  start-page: 531
  year: 2019
  end-page: 546
  article-title: Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular‐related diseases
  publication-title: Cellular and Molecular Neurobiology
– volume: 273
  start-page: 27765
  year: 1998
  end-page: 27767
  article-title: Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha‐secretase cleavage of the Alzheimer amyloid protein precursor
  publication-title: Journal of Biological Chemistry
– volume: 67
  start-page: 541
  year: 2018
  end-page: 553
  article-title: Neuronal exosome‐derived human tau is toxic to recipient mouse neurons in vivo
  publication-title: Journal of Alzheimer's Disease
– volume: 285
  start-page: 26279
  year: 2010
  end-page: 26288
  article-title: Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann‐Pick type C disease
  publication-title: Journal of Biological Chemistry
– volume: 6
  start-page: 47
  year: 2013
  article-title: Exosomes neutralize synaptic‐plasticity‐disrupting activity of Aβ assemblies in vivo
  publication-title: Molecular Brain
– volume: 9
  start-page: 9477
  year: 2019
  article-title: BIN1 favors the spreading of Tau via extracellular vesicles
  publication-title: Scientific Reports
– volume: 192
  start-page: 170
  year: 2018
  end-page: 187
  article-title: Extracellular vesicles and their nucleic acids for biomarker discovery
  publication-title: Pharmacology & Therapeutics
– volume: 108
  start-page: 319
  year: 2009
  end-page: 330
  article-title: Enhanced generation of Alzheimer’s amyloid‐β following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C
  publication-title: Journal of Neurochemistry
– volume: 582
  start-page: 1865
  year: 2008
  end-page: 1870
  article-title: p3 peptide, a truncated form of Aβ devoid of synaptotoxic effect, does not assemble into soluble oligomers
  publication-title: FEBS Letters
– volume: 8
  start-page: 31
  year: 2019
  article-title: Exploratory study on microRNA profiles from plasma‐derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies
  publication-title: Transl. Neurodegener.
– volume: 12
  start-page: 383
  year: 2018
  article-title: Alzheimer’s disease and Type 2 diabetes: A critical assessment of the shared pathological traits
  publication-title: Frontiers in Neuroscience
– volume: 12
  start-page: 61
  year: 2017
  article-title: Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A
  publication-title: Molecular Neurodegeneration
– volume: 11
  start-page: 7481
  year: 2019
  end-page: 7496
  article-title: Curcumin‐primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK‐3β pathway
  publication-title: Nanoscale
– volume: 2
  start-page: 769
  year: 2015a
  end-page: 773
  article-title: Low neural exosomal levels of cellular survival factors in Alzheimer’s disease
  publication-title: Annals of Clinical and Translational Neurology
– volume: 76
  start-page: 1340
  year: 2019
  end-page: 1351
  article-title: Association of extracellular vesicle biomarkers with alzheimer disease in the baltimore longitudinal study of aging
  publication-title: JAMA Neurology
– volume: 33
  start-page: 3758
  year: 2018
  end-page: 3771
  article-title: Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes
  publication-title: The FASEB Journal
– volume: 32
  start-page: 654
  year: 2017
  end-page: 668
  article-title: Exosomes derived from hypoxia‐preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice
  publication-title: The FASEB Journal
– volume: 45
  start-page: 495
  year: 2015
  end-page: 507
  article-title: Amyloid‐β modulates both AβPP and tau phosphorylation
  publication-title: Journal of Alzheimer's Disease
– volume: 126
  start-page: 5553
  year: 2013
  end-page: 5565
  article-title: Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles
  publication-title: Journal of Cell Science
– volume: 21
  start-page: 582
  year: 2014
  end-page: 593
  article-title: Microglia convert aggregated amyloid‐β into neurotoxic forms through the shedding of microvesicles
  publication-title: Cell Death and Differentiation
– volume: 2018
  start-page: 1
  year: 2018
  end-page: 27
  article-title: Isolation of extracellular vesicles: general methodologies and latest trends
  publication-title: BioMed Research International
– volume: 30
  start-page: 3853
  year: 2016
  end-page: 3859
  article-title: Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer’s disease
  publication-title: The FASEB Journal
– volume: 2017
  start-page: 8030369
  year: 2017
  article-title: Profiling microRNA from brain by microarray in a transgenic mouse model of Alzheimer’s disease
  publication-title: BioMed Research International
– volume: 14
  start-page: 27
  year: 2008
  end-page: 41
  article-title: Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways
  publication-title: Journal of Alzheimer's Disease
– volume: 8
  start-page: 237
  year: 2018
  end-page: 255
  article-title: Exosome theranostics: biology and translational medicine
  publication-title: Theranostics
– volume: 14
  start-page: 1626
  year: 2019
  end-page: 1634
  article-title: Mesenchymal stem cell‐derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer’s disease
  publication-title: Neural Regeneration Research
– volume: 21
  start-page: 708
  year: 2011
  end-page: 721
  article-title: The tetraspanin CD63 regulates ESCRT‐independent and ‐dependent endosomal sorting during melanogenesis
  publication-title: Developmental Cell
– volume: 19
  start-page: 79
  year: 2010
  end-page: 95
  article-title: Insulin‐degrading enzyme sorting in exosomes: A secretory pathway for a key brain amyloid‐beta degrading protease
  publication-title: Journal of Alzheimer's Disease
– volume: 20
  start-page: 1728
  year: 2019
  article-title: Extracellular vesicle as a source of Alzheimer’s biomarkers: opportunities and challenges
  publication-title: International Journal of Molecular Sciences
– volume: 74
  start-page: 391
  year: 2020
  end-page: 405
  article-title: Potential of FTIR spectroscopy applied to exosomes for Alzheimer’s disease discrimination: A pilot study
  publication-title: Journal of Alzheimer's Disease
– volume: 83
  start-page: 544
  year: 2018
  end-page: 552
  article-title: High complement levels in astrocyte‐derived exosomes of Alzheimer disease
  publication-title: Annals of Neurology
– volume: 56
  start-page: 5792
  year: 2019
  end-page: 5798
  article-title: SNAP‐25 in serum is carried by exosomes of neuronal origin and is a potential biomarker of Alzheimer’s disease
  publication-title: Molecular Neurobiology
– volume: 13
  start-page: 443
  year: 2019
  end-page: 450
  article-title: Exosomes and autophagy: Rekindling the vesicular waste hypothesis
  publication-title: Journal of Cell Communication and Signaling
– volume: 29
  start-page: 341
  year: 2011
  end-page: 345
  article-title: Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
  publication-title: Nature Biotechnology
– volume: 288
  start-page: 11649
  year: 2013
  end-page: 11661
  article-title: The intracellular interactome of tetraspanin‐enriched microdomains reveals their function as sorting machineries toward exosomes
  publication-title: Journal of Biological Chemistry
– volume: 33
  start-page: 231
  year: 2019
  end-page: 238
  article-title: Deficient neurotrophic factors of CSPG4‐type neural cell exosomes in Alzheimer disease
  publication-title: The FASEB Journal
– volume: 287
  start-page: 3842
  year: 2012
  end-page: 3849
  article-title: Exosome‐associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease
  publication-title: Journal of Biological Chemistry
– volume: 11
  year: 2013
  article-title: Neurotransmitter‐triggered transfer of exosomes mediates oligodendrocyte‐neuron communication
  publication-title: PLoS Biology
– volume: 60
  start-page: 305
  year: 2017
  end-page: 321
  article-title: Increased release of apolipoprotein e in extracellular vesicles following amyloid‐β protofibril exposure of neuroglial co‐cultures
  publication-title: Journal of Alzheimer's Disease
– volume: 287
  start-page: 43108
  year: 2012
  end-page: 43115
  article-title: The exosome secretory pathway transports amyloid precursor protein carboxyl‐terminal fragments from the cell into the brain extracellular space
  publication-title: Journal of Biological Chemistry
– volume: 43
  start-page: 2165
  year: 2018
  end-page: 2177
  article-title: Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid‐beta deposition by modulating microglial activation in alzheimer’s disease
  publication-title: Neurochemical Research
– volume: 9
  start-page: 12
  year: 2017
  article-title: Plasma exosomes spread and cluster around β‐amyloid plaques in an animal model of Alzheimer’s disease
  publication-title: Frontiers in Aging Neuroscience
– volume: 65
  start-page: 417
  year: 1991
  end-page: 427
  article-title: Late endosomes derive from early endosomes by maturation
  publication-title: Cell
– volume: 30
  start-page: 255
  year: 2014
  end-page: 289
  article-title: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles
  publication-title: Annual Review of Cell and Developmental Biology
– volume: 289
  start-page: 24488
  year: 2014
  end-page: 24498
  article-title: Decreased amyloid‐β pathologies by intracerebral loading of glycosphingolipid‐enriched exosomes in Alzheimer model mice
  publication-title: Journal of Biological Chemistry
– volume: 5
  start-page: 7989
  year: 2015
  article-title: Neuronal exosomes facilitate synaptic pruning by up‐regulating complement factors in microglia
  publication-title: Scientific Reports
– volume: 1691
  start-page: 87
  year: 2018
  end-page: 93
  article-title: The exosome of adipose‐derived stem cells reduces β‐amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer’s disease
  publication-title: Brain Research
– volume: 16
  start-page: 388
  year: 2019
  end-page: 395
  article-title: Characterization of serum exosomes from a transgenic mouse model of Alzheimer’s disease
  publication-title: Current Alzheimer Research
– volume: 85
  start-page: 40
  year: 2015b
  end-page: 47
  article-title: Altered lysosomal proteins in neural‐derived plasma exosomes in preclinical Alzheimer disease
  publication-title: Neurology
– volume: 7
  start-page: 182
  year: 2013
  article-title: Extracellular vesicles as mediators of neuron‐glia communication
  publication-title: Frontiers in Cellular Neuroscience
– volume: 1793
  start-page: 1901
  year: 2009
  end-page: 1916
  article-title: TI‐VAMP/VAMP7 and VAMP3/cellubrevin: Two v‐SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways
  publication-title: Biochimica Et Biophysica Acta ‐ Molecular Cell Research
– volume: 343
  start-page: 371
  issue: Pt 2
  year: 1999
  end-page: 375
  article-title: Membrane‐anchored metalloprotease MDC9 has an alpha‐secretase activity responsible for processing the amyloid precursor protein
  publication-title: The Biochemical Journal
– volume: 44
  start-page: 1113
  year: 2019
  end-page: 1126
  article-title: Resveratrol abrogates hypoxia‐induced up‐regulation of exosomal amyloid‐β partially by inhibiting CD147
  publication-title: Neurochemical Research
– volume: 211
  start-page: 27
  year: 2015
  end-page: 37
  article-title: RAL‐1 controls multivesicular body biogenesis and exosome secretion
  publication-title: Journal of Cell Biology
– volume: 7
  start-page: 789
  year: 2017
  end-page: 804
  article-title: Progress in exosome isolation techniques
  publication-title: Theranostics
– volume: 136
  start-page: 41
  year: 2018
  end-page: 56
  article-title: Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid‐beta oligomers
  publication-title: Acta Neuropathologica
– volume: 2
  start-page: a006270
  year: 2012
  article-title: Trafficking and proteolytic processing of APP
  publication-title: Cold Spring Harbor Perspectives in Medicine
– volume: 319
  start-page: 2
  year: 2018
  end-page: 6
  article-title: Blood‐based biomarkers for Alzheimer’s disease—An update
  publication-title: Journal of Neuroscience Methods
– volume: 103
  start-page: 11172
  year: 2006
  end-page: 11177
  article-title: Alzheimer’s disease beta‐amyloid peptides are released in association with exosomes
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
– volume: 6
  start-page: 10
  year: 2018
  article-title: Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons
  publication-title: Acta Neuropathologica Communications
– volume: 285
  start-page: 37405
  year: 2010
  end-page: 37414
  article-title: Statins promote the degradation of extracellular amyloid beta‐peptide by microglia via stimulation of exosome‐associated insulin‐degrading enzyme (IDE) secretion
  publication-title: Journal of Biological Chemistry
– volume: 10
  start-page: 1144
  year: 2019
  article-title: Subtyping of circulating exosome‐bound amyloid β reflects brain plaque deposition
  publication-title: Nature Communications
– volume: 40
  start-page: S47
  issue: Suppl 1
  year: 2014
  end-page: 70
  article-title: Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer’s disease
  publication-title: Journal of Alzheimer's Disease
– ident: e_1_2_9_77_1
  doi: 10.1371/journal.pone.0208580
– ident: e_1_2_9_13_1
  doi: 10.3233/JAD-2009-1177
– ident: e_1_2_9_115_1
  doi: 10.1074/jbc.M111.277061
– ident: e_1_2_9_59_1
  doi: 10.1074/jbc.M114.605253
– ident: e_1_2_9_78_1
  doi: 10.1002/prca.200700522
– ident: e_1_2_9_7_1
  doi: 10.1016/S0006-291X(02)02999-6
– ident: e_1_2_9_85_1
  doi: 10.3892/mmr.2014.2484
– ident: e_1_2_9_148_1
  doi: 10.1074/jbc.M117.818138
– ident: e_1_2_9_124_1
  doi: 10.1016/0092-8674(91)90459-C
– ident: e_1_2_9_76_1
  doi: 10.1155/2018/8545347
– ident: e_1_2_9_162_1
  doi: 10.3389/fnagi.2017.00012
– ident: e_1_2_9_63_1
  doi: 10.1016/j.jconrel.2015.03.033
– ident: e_1_2_9_108_1
  doi: 10.1073/pnas.0603838103
– ident: e_1_2_9_116_1
  doi: 10.3233/JAD-132135
– ident: e_1_2_9_5_1
  doi: 10.4132/jptm.2017.05.21
– ident: e_1_2_9_94_1
  doi: 10.1186/s40478-017-0445-5
– ident: e_1_2_9_98_1
  doi: 10.3233/JAD-142664
– ident: e_1_2_9_33_1
  doi: 10.3389/fphar.2017.00910
– ident: e_1_2_9_45_1
  doi: 10.3389/fncel.2019.00264
– ident: e_1_2_9_4_1
  doi: 10.1186/1756-6606-6-47
– ident: e_1_2_9_64_1
  doi: 10.7150/thno.21945
– ident: e_1_2_9_119_1
  doi: 10.1242/jcs.115.12.2505
– ident: e_1_2_9_143_1
  doi: 10.1186/s13024-016-0143-y
– ident: e_1_2_9_41_1
  doi: 10.1007/s11011-019-00438-9
– ident: e_1_2_9_44_1
  doi: 10.1111/j.1471-4159.2007.04587.x
– ident: e_1_2_9_117_1
  doi: 10.1007/s00401-018-1868-1
– ident: e_1_2_9_91_1
  doi: 10.1016/j.pharmthera.2018.08.002
– ident: e_1_2_9_111_1
  doi: 10.4103/1673-5374.255978
– ident: e_1_2_9_141_1
  doi: 10.1371/journal.pone.0041561
– ident: e_1_2_9_31_1
  doi: 10.1523/JNEUROSCI.1429-16.2016
– ident: e_1_2_9_36_1
  doi: 10.1016/j.bbamcr.2009.09.011
– ident: e_1_2_9_150_1
  doi: 10.1016/j.dadm.2016.04.001
– ident: e_1_2_9_8_1
  doi: 10.1038/srep07989
– ident: e_1_2_9_133_1
  doi: 10.1016/j.devcel.2011.08.019
– ident: e_1_2_9_79_1
  doi: 10.1016/j.mcn.2010.11.004
– ident: e_1_2_9_51_1
  doi: 10.1096/fj.201600756R
– ident: e_1_2_9_80_1
  doi: 10.1073/pnas.96.7.3922
– ident: e_1_2_9_135_1
  doi: 10.1007/s11010-009-0084-7
– ident: e_1_2_9_131_1
  doi: 10.1016/j.bbrc.2006.10.181
– ident: e_1_2_9_67_1
  doi: 10.1083/jcb.201504136
– ident: e_1_2_9_71_1
  doi: 10.1096/fj.14-262048
– ident: e_1_2_9_11_1
  doi: 10.1080/21541248.2016.1264352
– ident: e_1_2_9_20_1
  doi: 10.3402/jev.v3.24722
– ident: e_1_2_9_152_1
  doi: 10.1007/s11064-019-02742-3
– ident: e_1_2_9_158_1
  doi: 10.1016/j.febslet.2014.11.027
– ident: e_1_2_9_66_1
  doi: 10.1083/jcb.200911018
– ident: e_1_2_9_161_1
  doi: 10.1007/s12640-017-9713-1
– ident: e_1_2_9_28_1
  doi: 10.1186/s13024-019-0333-5
– ident: e_1_2_9_129_1
  doi: 10.1074/jbc.M110.149468
– ident: e_1_2_9_10_1
  doi: 10.1073/pnas.0308512100
– ident: e_1_2_9_110_1
  doi: 10.1007/s12031-007-0001-z
– ident: e_1_2_9_16_1
  doi: 10.1074/jbc.273.43.27765
– ident: e_1_2_9_70_1
  doi: 10.1523/JNEUROSCI.0387-15.2015
– ident: e_1_2_9_42_1
  doi: 10.1111/bpa.12699
– ident: e_1_2_9_96_1
  doi: 10.1096/fj.201700359
– ident: e_1_2_9_90_1
  doi: 10.1038/s41467-017-02533-w
– ident: e_1_2_9_40_1
  doi: 10.3389/fncel.2013.00182
– ident: e_1_2_9_136_1
  doi: 10.1038/ncomms13588
– ident: e_1_2_9_49_1
  doi: 10.1212/WNL.0000000000001702
– ident: e_1_2_9_138_1
  doi: 10.1074/jbc.M609475200
– ident: e_1_2_9_12_1
  doi: 10.1016/S0140-6736(06)69113-7
– ident: e_1_2_9_101_1
  doi: 10.1016/j.neuroscience.2018.04.003
– ident: e_1_2_9_103_1
  doi: 10.1074/jbc.M112.404467
– ident: e_1_2_9_160_1
  doi: 10.3171/2014.11.JNS14770
– ident: e_1_2_9_151_1
  doi: 10.1016/j.dadm.2018.11.002
– ident: e_1_2_9_126_1
  doi: 10.1111/j.1600-0854.2009.00920.x
– ident: e_1_2_9_23_1
  doi: 10.1146/annurev-cellbio-101512-122326
– ident: e_1_2_9_58_1
  doi: 10.1186/s13024-017-0165-0
– ident: e_1_2_9_35_1
  doi: 10.1038/npjamd.2016.19
– ident: e_1_2_9_38_1
  doi: 10.1016/j.jalz.2014.06.008
– ident: e_1_2_9_83_1
  doi: 10.7150/thno.18133
– ident: e_1_2_9_88_1
  doi: 10.1007/s12035-018-1032-x
– ident: e_1_2_9_104_1
  doi: 10.1074/jbc.M112.445304
– ident: e_1_2_9_105_1
  doi: 10.2217/bmm-2018-0034
– ident: e_1_2_9_140_1
  doi: 10.1039/C9NR01255A
– ident: e_1_2_9_9_1
  doi: 10.1007/s10571-019-00751-y
– ident: e_1_2_9_53_1
  doi: 10.1002/ana.25172
– ident: e_1_2_9_75_1
  doi: 10.1042/bj3430371
– ident: e_1_2_9_123_1
  doi: 10.3233/JAD-191034
– volume: 2017
  start-page: 8030369
  year: 2017
  ident: e_1_2_9_142_1
  article-title: Profiling microRNA from brain by microarray in a transgenic mouse model of Alzheimer’s disease
  publication-title: BioMed Research International
– ident: e_1_2_9_34_1
  doi: 10.1016/j.febslet.2008.05.002
– ident: e_1_2_9_95_1
  doi: 10.3233/JAD-170278
– ident: e_1_2_9_130_1
  doi: 10.3233/JAD-132144
– ident: e_1_2_9_61_1
  doi: 10.1016/j.jalz.2016.08.012
– ident: e_1_2_9_125_1
  doi: 10.1074/jbc.M110.134775
– ident: e_1_2_9_6_1
  doi: 10.1038/nn.4132
– ident: e_1_2_9_112_1
  doi: 10.2174/1567205016666190321155422
– ident: e_1_2_9_82_1
  doi: 10.3390/ijms20071728
– ident: e_1_2_9_134_1
  doi: 10.3389/fphar.2019.01452
– ident: e_1_2_9_14_1
  doi: 10.1093/brain/awq258
– ident: e_1_2_9_30_1
  doi: 10.1016/j.neurobiolaging.2014.02.012
– ident: e_1_2_9_74_1
  doi: 10.1038/srep01197
– ident: e_1_2_9_155_1
  doi: 10.1007/s11095-014-1593-y
– ident: e_1_2_9_37_1
  doi: 10.1016/j.biochi.2018.05.015
– ident: e_1_2_9_128_1
  doi: 10.1016/j.jalz.2019.06.4952
– ident: e_1_2_9_146_1
  doi: 10.1038/nature14864
– ident: e_1_2_9_145_1
  doi: 10.1007/s00702-008-0177-6
– ident: e_1_2_9_50_1
  doi: 10.1096/fj.201600816R
– ident: e_1_2_9_32_1
  doi: 10.2174/1567205014666170317113606
– ident: e_1_2_9_2_1
  doi: 10.1007/s12035-019-1501-x
– ident: e_1_2_9_47_1
  doi: 10.1096/fj.201700731R
– ident: e_1_2_9_65_1
  doi: 10.1038/srep30319
– ident: e_1_2_9_102_1
  doi: 10.1093/brain/awy289
– ident: e_1_2_9_122_1
  doi: 10.1371/journal.pone.0198820
– ident: e_1_2_9_69_1
  doi: 10.1038/cdd.2013.180
– ident: e_1_2_9_159_1
  doi: 10.1016/j.jneumeth.2018.10.025
– ident: e_1_2_9_43_1
  doi: 10.1186/s40035-019-0169-5
– ident: e_1_2_9_109_1
  doi: 10.3233/JAD-2010-1371
– ident: e_1_2_9_156_1
  doi: 10.1074/jbc.M111.324616
– ident: e_1_2_9_147_1
  doi: 10.1186/s13024-017-0203-y
– ident: e_1_2_9_60_1
  doi: 10.1101/cshperspect.a006270
– ident: e_1_2_9_144_1
  doi: 10.1016/j.neuroscience.2018.03.016
– ident: e_1_2_9_18_1
  doi: 10.3389/fnins.2018.00383
– ident: e_1_2_9_87_1
  doi: 10.1016/j.nbd.2018.02.014
– ident: e_1_2_9_17_1
  doi: 10.3389/fnins.2019.01208
– ident: e_1_2_9_97_1
  doi: 10.3233/JAD-170176
– ident: e_1_2_9_68_1
  doi: 10.1016/j.jalz.2019.05.002
– ident: e_1_2_9_39_1
  doi: 10.1371/journal.pbio.1001604
– ident: e_1_2_9_89_1
  doi: 10.1186/gm452
– ident: e_1_2_9_52_1
  doi: 10.1096/fj.201801001
– ident: e_1_2_9_26_1
  doi: 10.2174/187152710793237458
– ident: e_1_2_9_81_1
  doi: 10.1016/j.brainres.2018.03.034
– ident: e_1_2_9_27_1
  doi: 10.1111/j.1471-4159.2008.05770.x
– ident: e_1_2_9_113_1
  doi: 10.3389/fncel.2019.00051
– ident: e_1_2_9_157_1
  doi: 10.1074/jbc.M114.577213
– ident: e_1_2_9_3_1
  doi: 10.1038/nbt.1807
– ident: e_1_2_9_25_1
  doi: 10.1096/fj.201700600R
– ident: e_1_2_9_73_1
  doi: 10.1007/7651_2014_98
– ident: e_1_2_9_24_1
  doi: 10.1038/s41598-019-45676-0
– ident: e_1_2_9_120_1
  doi: 10.1016/j.cub.2012.01.028
– ident: e_1_2_9_62_1
  doi: 10.1038/s41582-018-0079-7
– ident: e_1_2_9_137_1
  doi: 10.1155/2016/2584940
– ident: e_1_2_9_100_1
  doi: 10.1096/fj.201801319R
– ident: e_1_2_9_121_1
  doi: 10.1096/fj.07-9357com
– ident: e_1_2_9_55_1
  doi: 10.1007/s12079-019-00524-8
– ident: e_1_2_9_93_1
  doi: 10.3233/JAD-180578
– ident: e_1_2_9_107_1
  doi: 10.1074/jbc.M115.709485
– ident: e_1_2_9_21_1
  doi: 10.3233/JAD-2008-14103
– ident: e_1_2_9_114_1
  doi: 10.2217/fon-2018-0812
– ident: e_1_2_9_56_1
  doi: 10.18632/oncotarget.6158
– ident: e_1_2_9_57_1
  doi: 10.3390/ijms19030663
– ident: e_1_2_9_54_1
  doi: 10.1093/nar/gku594
– ident: e_1_2_9_139_1
  doi: 10.1074/jbc.M112.340513
– ident: e_1_2_9_99_1
  doi: 10.1038/ncb2000
– ident: e_1_2_9_118_1
  doi: 10.1111/j.1600-0854.2004.00257.x
– volume: 31
  start-page: 87
  year: 2018
  ident: e_1_2_9_154_1
  article-title: The serum exosome derived microRNA‐135a, ‐193b, and ‐384 were potential Alzheimer’s disease biomarkers
  publication-title: Biomedical and Environmental Sciences
– ident: e_1_2_9_15_1
  doi: 10.3233/JAD-2010-1206
– ident: e_1_2_9_153_1
  doi: 10.1242/jcs.215210
– ident: e_1_2_9_149_1
  doi: 10.3233/JAD-180776
– ident: e_1_2_9_92_1
  doi: 10.1002/hbm.23494
– ident: e_1_2_9_127_1
  doi: 10.1016/S0002-9440(10)64463-X
– ident: e_1_2_9_29_1
  doi: 10.1007/s11064-018-2641-5
– ident: e_1_2_9_19_1
  doi: 10.1038/mp.2014.127
– ident: e_1_2_9_72_1
  doi: 10.1001/jamaneurol.2019.2462
– ident: e_1_2_9_106_1
  doi: 10.1186/s40478-018-0514-4
– ident: e_1_2_9_22_1
  doi: 10.1242/jcs.128868
– ident: e_1_2_9_86_1
  doi: 10.1371/journal.pone.0139233
– ident: e_1_2_9_84_1
  doi: 10.1038/s41467-019-09030-2
– ident: e_1_2_9_46_1
  doi: 10.1016/j.neurobiolaging.2009.08.013
– ident: e_1_2_9_132_1
  doi: 10.1126/science.1153124
– ident: e_1_2_9_48_1
  doi: 10.1002/acn3.211
SSID ssj0016461
Score 2.643467
SecondaryResourceType review_article
Snippet Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 162
SubjectTerms Alzheimer Disease
Alzheimer's Disease
Animals
biomarker
Biomarkers
diagnosis
Diagnostic systems
exosome
Exosomes
Humans
miRNA
Neurodegenerative diseases
Pathogenesis
therapeutics
Title Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.15112
https://www.ncbi.nlm.nih.gov/pubmed/32618370
https://www.proquest.com/docview/2484906819
https://www.proquest.com/docview/2420135400
Volume 156
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 1471-4159
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0016461
  issn: 0022-3042
  databaseCode: HH5
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1471-4159
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0016461
  issn: 0022-3042
  databaseCode: DIK
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1471-4159
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0016461
  issn: 0022-3042
  databaseCode: GX1
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVALS
  databaseName: IngentaConnect Open Access Journals (Selected full-text)
  customDbUrl:
  eissn: 1471-4159
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0016461
  issn: 0022-3042
  databaseCode: FIJ
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://www.ingentaconnect.com/content/title?j_type=online&j_startat=Aa&j_endat=Af&j_pagesize=200&j_page=1
  providerName: Ingenta
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0022-3042
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1471-4159
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0016461
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7IXvTF27xM54gi4kul6dquw6cxFTfRB3Hgg1CaJsHh1o51A92Tf8O_5y_xJL0wbyC-lfakTZNzku_knHwBOOR15oqQC8Np1Jlh1xkzmh5rGALBPeLzBo6Jar_z9Y172bO79879Apzme2FSfohiwU1Zhh6vlYEHLJk3crQfquACjr-07ugQ7W1BHaVos2jBFI6ambEK6SyevOTnuegbwPyMV_WEc7ECD3lV0zyTp5PphJ2Esy8sjv_8l1VYzoAoaaWaswYLIlqHcitCJ3z4Qo6ITg3Va-7rsNjOj4UrQ-csTc7DYiSIOJnbwEVG8UQlH-FrY0nEc5zEQ5GQfkRag9mj6A_F-P31LSFZUGgDehfnd-1LIzuPwQhVrBgnM67pybzA4xLtNggRDbiKIt-SrBFS7uBNhBA2t2xX2LLJJHcC6nDTC1yOrvAmlKI4EttAzEAKGbqUW1TaXHqeEA7lLjel8rEkq8Bx3jN-mJGVqzMzBn7htEShr5usAgeF6Chl6PhJqJp3r58ZaeJbtmc3TRcxUQX2i8fYnCpmEkQinioZREhqbcyswFaqFsVXEPlSxR2EldWd-_vn_e5NW1_s_F10F5YslT-jl3uqUJqMp2IPAdCE1VDTO1c1re8fZUgBbA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB0VOMCFfSmrQQhxSZWkSZpKXKpCVaD0gEDigqI4tgWCJoi2EnDiN_g9voQZZxFlkRC3KBknju2x3yx-BtgVVe7JSEjDrVW54VQ5N-o-rxkSwT3i8xrOibTf-azrtS-dkyv3qgQH-V6YlB-icLiRZuj5mhScHNKftRwVyCK8MAYTFJ8jtTw8L8ijiDjLKrjCcWxmvEI6jycvOroafYOYo4hVLzmtGbjOK5tmmtxVhgNeiV6-8Dj-929mYTrDoqyRDp45KMl4HhYaMdrhvWe2x3R2qHa7z8NkMz8ZbgGOD9P8PCzGwliwT3u42EMyoPwjfG2imHxK-klP9tltzBr3Lzfyticf31_f-iyLCy3CZevootk2siMZjIjCxbieCc1Q5oe-UKi6YYSAwCOWfFvxWmQJF28iinCE7XjSUXWuhBtarjD90BNoDS_BeJzEcgWYGSqpIs8StqUcoXxfStcSnjAVmVmKl2E_75ogyvjK6diM-6CwW-Io0E1Whp1C9CEl6fhJaD3v3yDT035gO75TNz2ERWXYLh5jc1LYJIxlMiQZBEnkHjPLsJyOi-IrCH4tog_Cyure_f3zwUm3qS9W_y66BZPti7NO0Dnunq7BlE3pNNr7sw7jg8eh3EA8NOCbeth_AGFIBI8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB48QH3xPtYziogvlbabZrv4tKwunouIgg9CaZoERbdd9gDdJ_-Gf89f4iQ98ATxrbSTNk1mkm8mky8A26LMmYyEtLxKmVu0zLlV9XnFkgjuEZ9XcEzU-53Pm-zomp7ceDdDsJ_vhUn5IYqAm7YMM15rA28L9dHI0X4cDReGYZQy9K40IrosuKM0b5ZTUIWjama0QiaNJy_6eTL6hjA_A1Yz4zSm4Dava5po8rDX7_G9aPCFxvGfPzMNkxkSJbVUdWZgSMazMFeL0QtvPZMdYnJDTdB9Fsbr-blwc3B8kGbnYTESxoJ82MFF2klPZx_haxNF5FPSTVqyS-5jUnsc3Mn7luy8vbx2SbYqNA_XjcOr-pGVHchgRXqxGGczYfjJ_NAXCg03jBAOMM2R7ypeiRzh4U3EEFS4lEmqqlwJL3Q8YfshE-gLL8BInMRyCYgdKqki5gjXUVQo35fScwQTttJOluIl2M17JogytnJ9aMZjUHgtcRSYJivBViHaTik6fhJazbs3yKy0G7jUp1WbISgqwWbxGJtTL5qEsUz6WgYhkg6O2SVYTNWi-ApCX0eTB2FlTef-_vngpFk3F8t_F92AsYuDRnB23DxdgQlX59KY0M8qjPQ6fbmGYKjH143SvwNTbQM-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+and+therapeutic+potential+of+exosomes+in+Alzheimer%E2%80%99s+disease&rft.jtitle=Journal+of+neurochemistry&rft.au=T%C3%A2nia+Soares+Martins&rft.au=Trindade%2C+D%C3%A1rio&rft.au=Vaz%2C+Margarida&rft.au=Campelo%2C+In%C3%AAs&rft.date=2021-01-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=156&rft.issue=2&rft.spage=162&rft.epage=181&rft_id=info:doi/10.1111%2Fjnc.15112&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon